We hear from Professor Rob Clarke, a Breast Cancer Now researcher based at the University of Manchester. He shares how the work in his lab restarted after over a three-month closure due to COVID-19.
Study has suggested that immunotherapy could be effective against some cancers with changes in BRCA genes that become resistant to treatment.
We hear from Dr Anna Git, a Breast Cancer Now scientist based at the University of Cambridge. She shares how her research has been put on hold after her lab closed due to COVID-19.
We speak to Dr Natasha Malik is a Breast Cancer Now researcher at the University of Glasgow who volunteered to join a coronavirus testing lab when her work was paused by the pandemic.
While a lot of lab-based research is currently on hold due to COVID-19, the Breast Cancer Now Generations Study continues.
A study has found that adding two hormone measurements to a breast cancer risk prediction tool can increase its accuracy for women aged 35-50.
We hear from Dr Niamh Buckley, a Breast Cancer Now Fellow based at Queen’s University Belfast. She shares how she has been working from home after her lab closed due to COVID-19.
Researchers help clinicians select the best possible treatment for women with oestrogen receptor positive breast cancer during the COVID-19 pandemic.
Dr Simon Vincent, Director of Research at Breast Cancer Now, shares how COVID-19 has affected Breast Cancer Now’s research.